Technical analysis of PMGC Holdings Inc. (ELAB): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
PMGC Holdings Inc. functions as a biopharmaceutical firm, primarily dedicated to sourcing and advancing innovative aesthetic and therapeutic solutions. Its flagship product, EL-22, is a pioneering engineered probiotic designed to tackle the critical challenge of maintaining muscle mass during weight reduction regimens, especially those utilizing GLP-1 receptor agonists.
Price Performance
| 1 month | -42.53% |
| 3 months | -65.68% |
| Year-to-date | -99.66% |
| 1 year | -99.91% |
52-Week Range
| 52-week High | $10684.80 |
| 52-week Low | $4.40 |
| Avg Volume (90d) | 221K |
Technical Indicators
| SMA 50 | $7.98 |
| SMA 200 | $435.58 |
| Beta | 0.71 |
| 30-day Volatility (annualised) | 131.3% |
| Price vs SMA 50 | -40.2% |
| Price vs SMA 200 | -98.9% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $5692.80 | |
| 2025-11 | $5097.60 | -10.5% |
| 2025-12 | $1420.80 | -72.1% |
| 2026-01 | $210.60 | -85.2% |
| 2026-02 | $71.40 | -66.1% |
| 2026-03 | $59.90 | -16.1% |
| 2026-04 | $24.60 | -58.9% |
| 2026-05 | $17.70 | -28.0% |
| 2026-06 | $12.10 | -31.6% |
| 2026-07 | $9.23 | -23.7% |
| 2026-08 | $5.19 | -43.8% |
| 2026-09 | $4.77 | -8.1% |
Price
| Price | $4.77 |
| Market Cap | $2M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.14 |
| EV / EBITDA | -0.02 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.83 |
| Current Ratio | 1.36 |